nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—GHRHR—brainstem—narcolepsy	0.0657	0.0944	CbGeAlD
Docetaxel—GHRHR—brain—narcolepsy	0.0263	0.0378	CbGeAlD
Docetaxel—MAP4—brainstem—narcolepsy	0.0258	0.037	CbGeAlD
Docetaxel—MAP4—forebrain—narcolepsy	0.0249	0.0357	CbGeAlD
Docetaxel—GHRHR—GPCRs, Other—P2RY11—narcolepsy	0.0232	0.0763	CbGpPWpGaD
Docetaxel—MAPT—medulla oblongata—narcolepsy	0.0228	0.0328	CbGeAlD
Docetaxel—BCL2—forebrain—narcolepsy	0.0226	0.0325	CbGeAlD
Docetaxel—KIF11—brain—narcolepsy	0.0224	0.0322	CbGeAlD
Docetaxel—MAPT—midbrain—narcolepsy	0.0209	0.03	CbGeAlD
Docetaxel—MAP2—brainstem—narcolepsy	0.0203	0.0291	CbGeAlD
Docetaxel—MAP2—forebrain—narcolepsy	0.0196	0.0281	CbGeAlD
Docetaxel—GHRHR—G alpha (s) signalling events—P2RY11—narcolepsy	0.0181	0.0595	CbGpPWpGaD
Docetaxel—MAP4—medulla oblongata—narcolepsy	0.018	0.0258	CbGeAlD
Docetaxel—MAP4—midbrain—narcolepsy	0.0164	0.0236	CbGeAlD
Docetaxel—TUBB4A—brainstem—narcolepsy	0.0157	0.0225	CbGeAlD
Docetaxel—TUBB4A—forebrain—narcolepsy	0.0151	0.0217	CbGeAlD
Docetaxel—TUBB8—brain—narcolepsy	0.0151	0.0217	CbGeAlD
Docetaxel—TUBB2B—forebrain—narcolepsy	0.0146	0.021	CbGeAlD
Docetaxel—BCL2—IL2-mediated signaling events—SOCS2—narcolepsy	0.0143	0.0469	CbGpPWpGaD
Docetaxel—MAP2—medulla oblongata—narcolepsy	0.0141	0.0203	CbGeAlD
Docetaxel—TUBB2A—forebrain—narcolepsy	0.0138	0.0198	CbGeAlD
Docetaxel—MAPT—brain—narcolepsy	0.0131	0.0189	CbGeAlD
Docetaxel—MAP2—midbrain—narcolepsy	0.0129	0.0186	CbGeAlD
Docetaxel—TUBB4B—forebrain—narcolepsy	0.0118	0.017	CbGeAlD
Docetaxel—TUBB4A—medulla oblongata—narcolepsy	0.0109	0.0157	CbGeAlD
Docetaxel—TUBB2B—medulla oblongata—narcolepsy	0.0106	0.0152	CbGeAlD
Docetaxel—MAP4—brain—narcolepsy	0.0103	0.0148	CbGeAlD
Docetaxel—TUBB3—brain—narcolepsy	0.0103	0.0148	CbGeAlD
Docetaxel—TUBB1—brain—narcolepsy	0.0101	0.0145	CbGeAlD
Docetaxel—TUBB—medulla oblongata—narcolepsy	0.01	0.0144	CbGeAlD
Docetaxel—TUBB4A—midbrain—narcolepsy	0.00999	0.0144	CbGeAlD
Docetaxel—TUBB2A—medulla oblongata—narcolepsy	0.00994	0.0143	CbGeAlD
Docetaxel—TUBB6—medulla oblongata—narcolepsy	0.00981	0.0141	CbGeAlD
Docetaxel—TUBB2B—midbrain—narcolepsy	0.00965	0.0139	CbGeAlD
Docetaxel—BCL2—brain—narcolepsy	0.00938	0.0135	CbGeAlD
Docetaxel—EGFR—brain—narcolepsy	0.00926	0.0133	CbGeAlD
Docetaxel—TUBB—midbrain—narcolepsy	0.00914	0.0131	CbGeAlD
Docetaxel—TUBB2A—midbrain—narcolepsy	0.00909	0.0131	CbGeAlD
Docetaxel—KIF11—MHC class II antigen presentation—HLA-DQA1—narcolepsy	0.00897	0.0295	CbGpPWpGaD
Docetaxel—TUBB6—midbrain—narcolepsy	0.00896	0.0129	CbGeAlD
Docetaxel—ABCC10—medulla oblongata—narcolepsy	0.00859	0.0123	CbGeAlD
Docetaxel—TUBB4B—medulla oblongata—narcolepsy	0.00852	0.0123	CbGeAlD
Docetaxel—GHRHR—G alpha (s) signalling events—NPS—narcolepsy	0.00848	0.0279	CbGpPWpGaD
Docetaxel—KIF11—MHC class II antigen presentation—HLA-DQB1—narcolepsy	0.00839	0.0276	CbGpPWpGaD
Docetaxel—MAP2—brain—narcolepsy	0.00812	0.0117	CbGeAlD
Docetaxel—ABCC10—midbrain—narcolepsy	0.00785	0.0113	CbGeAlD
Docetaxel—TUBB4B—midbrain—narcolepsy	0.00779	0.0112	CbGeAlD
Docetaxel—SLC22A7—brain—narcolepsy	0.00702	0.0101	CbGeAlD
Docetaxel—GHRHR—GPCR ligand binding—HCRTR1—narcolepsy	0.00681	0.0224	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—HCRTR2—narcolepsy	0.00681	0.0224	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—P2RY11—narcolepsy	0.00658	0.0216	CbGpPWpGaD
Docetaxel—GHRHR—GPCRs, Other—HTR2A—narcolepsy	0.00653	0.0215	CbGpPWpGaD
Docetaxel—KIF11—MHC class II antigen presentation—HLA-DRB1—narcolepsy	0.00638	0.021	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00629	0.0207	CbGpPWpGaD
Docetaxel—TUBB4A—brain—narcolepsy	0.00628	0.00902	CbGeAlD
Docetaxel—TUBB2B—brain—narcolepsy	0.00607	0.00872	CbGeAlD
Docetaxel—TUBB—brain—narcolepsy	0.00574	0.00825	CbGeAlD
Docetaxel—TUBB2A—brain—narcolepsy	0.00571	0.00821	CbGeAlD
Docetaxel—TUBB6—brain—narcolepsy	0.00563	0.00809	CbGeAlD
Docetaxel—GHRHR—GPCR ligand binding—HCRT—narcolepsy	0.00559	0.0184	CbGpPWpGaD
Docetaxel—ABCG2—medulla oblongata—narcolepsy	0.00503	0.00723	CbGeAlD
Docetaxel—GHRHR—GPCR ligand binding—PENK—narcolepsy	0.00498	0.0164	CbGpPWpGaD
Docetaxel—ABCC10—brain—narcolepsy	0.00493	0.00709	CbGeAlD
Docetaxel—TUBB4B—brain—narcolepsy	0.0049	0.00704	CbGeAlD
Docetaxel—KIF11—Immune System—SOCS2—narcolepsy	0.00478	0.0157	CbGpPWpGaD
Docetaxel—ABCG2—midbrain—narcolepsy	0.0046	0.0066	CbGeAlD
Docetaxel—GHRHR—GPCR ligand binding—TRH—narcolepsy	0.00424	0.0139	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNFRSF1B—narcolepsy	0.00399	0.0131	CbGpPWpGaD
Docetaxel—CYP1B1—brain—narcolepsy	0.00388	0.00557	CbGeAlD
Docetaxel—GHRHR—GPCR downstream signaling—HCRTR1—narcolepsy	0.00385	0.0126	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—HCRTR2—narcolepsy	0.00385	0.0126	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00378	0.0124	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TNFRSF1B—narcolepsy	0.00374	0.0123	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—P2RY11—narcolepsy	0.00372	0.0122	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—HRH3—narcolepsy	0.00372	0.0122	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HCRTR2—narcolepsy	0.00349	0.0115	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HCRTR1—narcolepsy	0.00349	0.0115	CbGpPWpGaD
Docetaxel—ABCC1—brain—narcolepsy	0.00349	0.00501	CbGeAlD
Docetaxel—ABCB1—forebrain—narcolepsy	0.00343	0.00493	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—P2RY11—narcolepsy	0.00337	0.0111	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—HCRT—narcolepsy	0.00316	0.0104	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—TAC1—narcolepsy	0.00308	0.0101	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—NPS—narcolepsy	0.00308	0.0101	CbGpPWpGaD
Docetaxel—BCL2—Overview of nanoparticle effects—TNF—narcolepsy	0.00302	0.00994	CbGpPWpGaD
Docetaxel—ABCG2—brain—narcolepsy	0.00289	0.00415	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—HCRT—narcolepsy	0.00287	0.00943	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—PENK—narcolepsy	0.00282	0.00926	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—PENK—narcolepsy	0.00256	0.00841	CbGpPWpGaD
Docetaxel—ABCB1—medulla oblongata—narcolepsy	0.00248	0.00356	CbGeAlD
Docetaxel—GHRHR—GPCR downstream signaling—TRH—narcolepsy	0.00239	0.00787	CbGpPWpGaD
Docetaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—narcolepsy	0.00235	0.00773	CbGpPWpGaD
Docetaxel—ABCB1—midbrain—narcolepsy	0.00227	0.00326	CbGeAlD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00219	0.00721	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00219	0.00721	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—TRH—narcolepsy	0.00217	0.00715	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00215	0.00708	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00212	0.00696	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—HRH3—narcolepsy	0.0021	0.0069	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HCRTR1—narcolepsy	0.00206	0.00679	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HCRTR2—narcolepsy	0.00206	0.00679	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00201	0.00662	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—P2RY11—narcolepsy	0.00199	0.00655	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—CTNNBL1—narcolepsy	0.00198	0.0065	CbGpPWpGaD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—narcolepsy	0.00194	0.00639	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HRH3—narcolepsy	0.00191	0.00627	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—HTR2A—narcolepsy	0.00185	0.00609	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0018	0.00592	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—NPS—narcolepsy	0.00174	0.00572	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—TAC1—narcolepsy	0.00174	0.00572	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—narcolepsy	0.00174	0.00571	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00172	0.00564	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HCRT—narcolepsy	0.00169	0.00557	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00163	0.00535	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—narcolepsy	0.0016	0.00527	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—TAC1—narcolepsy	0.00158	0.00519	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—NPS—narcolepsy	0.00158	0.00519	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TNF—narcolepsy	0.00157	0.00517	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DRB1—narcolepsy	0.00153	0.00504	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PENK—narcolepsy	0.00151	0.00497	CbGpPWpGaD
Docetaxel—BCL2—Ceramide signaling pathway—TNF—narcolepsy	0.00144	0.00473	CbGpPWpGaD
Docetaxel—ABCB1—brain—narcolepsy	0.00142	0.00205	CbGeAlD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00136	0.00449	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-DQA1—narcolepsy	0.00131	0.0043	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TRH—narcolepsy	0.00128	0.00422	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—TNF—narcolepsy	0.00126	0.00413	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SOCS2—narcolepsy	0.00125	0.00411	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-DQB1—narcolepsy	0.00122	0.00402	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00121	0.00399	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00117	0.00386	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00117	0.00384	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRH3—narcolepsy	0.00113	0.0037	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—HTR2A—narcolepsy	0.00105	0.00344	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000992	0.00326	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000992	0.00326	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HTR2A—narcolepsy	0.00095	0.00312	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NPS—narcolepsy	0.000933	0.00307	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TAC1—narcolepsy	0.000933	0.00307	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-DRB1—narcolepsy	0.000929	0.00305	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—narcolepsy	0.00092	0.00303	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TNF—narcolepsy	0.000917	0.00301	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000904	0.00297	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000904	0.00297	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000881	0.0029	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000881	0.0029	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TNF—narcolepsy	0.00086	0.00283	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.000858	0.00282	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000825	0.00271	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000803	0.00264	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000798	0.00262	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000776	0.00255	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CHKB—narcolepsy	0.000764	0.00251	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SOCS2—narcolepsy	0.000739	0.00243	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HCRTR2—narcolepsy	0.000635	0.00209	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HCRTR1—narcolepsy	0.000635	0.00209	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—P2RY11—narcolepsy	0.000613	0.00202	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00061	0.00201	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000597	0.00196	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—narcolepsy	0.000564	0.00185	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HTR2A—narcolepsy	0.000561	0.00185	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CHKB—narcolepsy	0.00054	0.00178	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CHKB—narcolepsy	0.000523	0.00172	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HCRT—narcolepsy	0.000521	0.00171	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CPT1B—narcolepsy	0.000519	0.00171	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000477	0.00157	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CHKB—narcolepsy	0.000475	0.00156	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CHKB—narcolepsy	0.000471	0.00155	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PENK—narcolepsy	0.000465	0.00153	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—narcolepsy	0.000415	0.00136	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TRH—narcolepsy	0.000395	0.0013	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HCRTR2—narcolepsy	0.000375	0.00123	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HCRTR1—narcolepsy	0.000375	0.00123	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CPT1B—narcolepsy	0.000367	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—P2RY11—narcolepsy	0.000362	0.00119	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CPT1B—narcolepsy	0.000355	0.00117	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRH3—narcolepsy	0.000346	0.00114	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DQA1—narcolepsy	0.000341	0.00112	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CHKB—narcolepsy	0.000341	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000333	0.00109	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CPT1B—narcolepsy	0.000323	0.00106	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CPT1B—narcolepsy	0.00032	0.00105	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DQB1—narcolepsy	0.000319	0.00105	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—narcolepsy	0.000313	0.00103	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000311	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HCRT—narcolepsy	0.000308	0.00101	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000288	0.000948	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NPS—narcolepsy	0.000287	0.000944	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TAC1—narcolepsy	0.000287	0.000944	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000282	0.000927	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PENK—narcolepsy	0.000274	0.000902	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CHKB—narcolepsy	0.000257	0.000845	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DRB1—narcolepsy	0.000243	0.000798	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000237	0.000778	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TRH—narcolepsy	0.000233	0.000767	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CPT1B—narcolepsy	0.000232	0.000761	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRH3—narcolepsy	0.000205	0.000673	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQA1—narcolepsy	0.000202	0.000663	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQB1—narcolepsy	0.000189	0.000621	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CPT1B—narcolepsy	0.000175	0.000574	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HTR2A—narcolepsy	0.000173	0.000568	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TAC1—narcolepsy	0.00017	0.000557	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NPS—narcolepsy	0.00017	0.000557	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CHKB—narcolepsy	0.000158	0.000521	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DRB1—narcolepsy	0.000144	0.000472	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000142	0.000468	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—narcolepsy	0.000132	0.000434	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000108	0.000354	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR2A—narcolepsy	0.000102	0.000335	CbGpPWpGaD
